Acuson sells 10 echo units to Health First
Ultrasound vendor Acuson scored a coup this month when it sold 10 echocardiography systems, combined with its KinetDx PACS product, to Health First Heart Institute of Brevard, FL. Health First has installed one of Acuson’s Aspen units and
Ultrasound vendor Acuson scored a coup this month when it sold 10 echocardiography systems, combined with its KinetDx PACS product, to Health First Heart Institute of Brevard, FL. Health First has installed one of Acusons Aspen units and nine of its Sequoia C256 units, along with KinetDx, at hospitals and clinics in its network: Cape Canaveral Hospital, Palm Bay Community Hospital, Health First Healthplex Outpatient Clinic, and Holmes Regional Medical Center. The Aspen and Sequoia systems will include Acusons Imagegate hardware and software upgrade package, which it launched in September (SCAN 9/15/99).
Acuson introduced KinetDx in April at the Symposium for Computer Applications in Radiology in Houston (SCAN 5/12/99). KinetDx will link all four of Health Firsts facilities into a single network.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
